Prof. Kui Liu | Breast Cancer | Best Researcher Award

Prof. Kui Liu | Breast Cancer | Best Researcher Award

Zibo Central Hospital | China

AUTHOR PROFILE

Scopus

KUI LIU, Ph.D. – PROFESSIONAL PROFILE

🎓 EARLY ACADEMIC PURSUITS

Kui Liu embarked on a robust academic journey in clinical and diagnostic sciences:

  • 2002-2005: Completed a degree in Clinical Laboratory Medicine from Linyi Medical College, China.
  • 2012-2015: Pursued a master’s degree in Clinical Laboratory Diagnostics at Jiangsu University, Zhenjiang, China.
  • 2016-2020: Earned a Ph.D. in Immunology from Southeast University, Nanjing, China, contributing significantly to the field with innovative research in immune responses and diagnostics.

💼 PROFESSIONAL ENDEAVORS

Kui Liu has accumulated extensive clinical and technical experience over nearly two decades:

  • 2020-Present: Associate Chief Technician at the Center of Translational Medicine, Zibo Central Hospital, where he plays a key role in integrating research with clinical applications.
  • 2015-2016: Worked as a Docimaster at the Blood Bank of the First Hospital of Zibo, focusing on blood storage and safety protocols.
  • 2008-2012: Served as a Docimaster at the same institution, ensuring high-quality diagnostic practices.
  • 2005-2008: Began his career as a Docimaster in the Laboratory Department, excelling in clinical diagnostics.

🧪 CONTRIBUTIONS AND RESEARCH FOCUS ON BREAST CANCER

Kui Liu’s research is centered on advancing the fields of immunology and clinical diagnostics, with a focus on:

  • The study of immune responses in various pathological conditions.
  • Development of innovative diagnostic tools and techniques.
  • Translation of scientific research into clinical solutions.

His work on immune mechanisms and diagnostic technologies has led to groundbreaking advancements in translational medicine.

💡 FUNDING AND RESEARCH IMPACT

Kui Liu has been a driving force behind several high-impact research projects, securing prestigious grants to fund cutting-edge studies:

  • Grant no. 81602330: Principal Investigator for the National Natural Science Foundation of China (2017-2019), focusing on immunological research.
  • Grant no. 81972002: Co-Investigator for the National Natural Science Foundation of China (2019-2022), contributing to collaborative advancements in the field.
  • Grant no. J18KA299: Co-Investigator in the Shandong Province Higher Educational Science and Technology Program (2019-2021).
  • Grant no. ZR2015PH056: Co-Investigator for the Natural Science Foundation of Shandong Province (2015-2016).
  • Grant no. CXLX13_689: Principal Investigator for the Innovation Project of Cultivating Graduates of Jiangsu Province (2013-2015).

🌍 IMPACT AND INFLUENCE

  • Innovator in Translational Medicine: Kui Liu has bridged the gap between laboratory research and clinical application, enhancing diagnostic capabilities in immunology.
  • National and Regional Contributions: Through leadership in provincial and national projects, he has elevated the standards of diagnostic medicine across China.
  • Collaboration and Mentorship: Actively fosters collaborations and guides aspiring researchers, contributing to the growth of the next generation of medical scientists.

📚 ACADEMIC CITES AND RECOGNITION

Kui Liu has received widespread recognition for his contributions, reflected in numerous citations and acknowledgments in scientific journals. His findings have influenced medical practices and inspired continued exploration in immunology.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

Kui Liu’s career is a testament to his commitment to advancing medical science. His future endeavors include:

  • Leading innovative studies in immunological diagnostics.
  • Expanding the applications of translational medicine.
  • Continuing to inspire young researchers through mentorship and collaboration.

🌟CONCLUSION 

Dr. Kui Liu’s remarkable journey from foundational clinical studies to advanced immunological research exemplifies a career dedicated to innovation, excellence, and impact. His contributions to translational medicine and diagnostics have not only advanced scientific understanding but also improved clinical practices, particularly in immunology.

 

📊🔬NOTABLE PUBLICATION:
    1. Title: LncRNA DANCR-miR-758-3p-PAX6 Molecular Network Regulates Apoptosis and Autophagy of Breast Cancer Cells
      • Authors: Zhang, X.H., Li, B.F., Ding, J., Ma, F.X., Wu, X.Y.
      • Journal: Cancer Management and Research
      • Year: 2020

    1. Title: LncRNA PVT1 Regulates Gallbladder Cancer Progression through miR-30d-5p
      • Authors: Liu, K., Xu, Q.
      • Journal: Journal of Biological Regulators and Homeostatic Agents
      • Year: 2020

    1. Title: TIPE1 Inhibits Osteosarcoma Tumorigenesis and Progression by Regulating PRMT1 Mediated STAT3 Arginine Methylation
      • Authors: Yang, M., Zhang, Y., Liu, G., Liu, Q., Zhao, P.
      • Journal: Cell Death and Disease
      • Year: 2022

    1. Title: CircRNA hsa_circ_0008500 Acts as a miR-1301-3p Sponge to Promote Osteoblast Mineralization by Upregulating PADI4
      • Authors: Zhai, Q., Zhao, Y., Wang, L., Li, T., Wang, L.
      • Journal: Frontiers in Cell and Developmental Biology
      • Year: 2020

    1. Title: miR-369-3p Inhibits Tumorigenesis of Hepatocellular Carcinoma by Binding to PAX6
      • Authors: Xu, Q., Liu, K.
      • Journal: Journal of Biological Regulators and Homeostatic Agents
      • Year: 2020

Dr. Na Wang | Chemotherapy | Best Researcher Award

Dr. Na Wang | Chemotherapy | Best Researcher Award

First Affiliated Hospital of Xi’an Jiaotong University | China

AUTHOR PROFILE

Scopus

📘 DR. NA WANG, DEPARTMENT OF RESPIRATORY AND CRITICAL CARE MEDICINE, FIRST AFFILIATED HOSPITAL OF XI’AN JIAOTONG UNIVERSITY

🏫 EARLY ACADEMIC PURSUITS

Dr. Na Wang embarked on a distinguished academic journey, laying a strong foundation in respiratory medicine and critical care. She pursued her medical degree with a focus on respiratory health, demonstrating exceptional dedication and a commitment to addressing complex medical challenges. Her postgraduate studies were marked by advanced training in pulmonology, where she honed her expertise in the diagnosis and management of respiratory diseases.


🏥 PROFESSIONAL ENDEAVORS

Currently serving at the First Affiliated Hospital of Xi’an Jiaotong University, Dr. Wang plays a pivotal role in the Department of Respiratory and Critical Care Medicine. She has contributed significantly to clinical care, focusing on Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) and the broader spectrum of critical care management. Dr. Wang is recognized for her ability to translate complex clinical scenarios into innovative therapeutic strategies, improving patient outcomes.


🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CHEMOTHERAPY

Dr. Wang’s research is centered on Chronic Obstructive Pulmonary Disease (COPD), particularly its acute exacerbations, which are leading causes of hospitalization and mortality worldwide. Her studies delve into:

  • The pathophysiological mechanisms underlying AECOPD.
  • Biomarker identification for early diagnosis and prognosis.
  • Innovative therapeutic approaches, including pharmacological and non-pharmacological strategies.
    Her work bridges clinical insights with translational research, contributing to the development of effective treatment modalities.

🌟 IMPACT AND INFLUENCE

Dr. Wang’s research has had a profound impact on the respiratory medicine field, especially in China. Her findings have been instrumental in shaping clinical guidelines for AECOPD management, benefiting countless patients. She is a sought-after speaker at national and international conferences, sharing her expertise on managing critical respiratory conditions.


📚 ACADEMIC CITES

With a growing body of published works, Dr. Wang has contributed extensively to peer-reviewed journals. Her articles are widely cited, reflecting the significance of her research. She continues to advance the field through collaborations with leading respiratory medicine experts and research teams globally.


🌏 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Na Wang is poised to leave an enduring legacy in respiratory and critical care medicine. Her commitment to:

  1. Advancing knowledge in AECOPD management.
  2. Mentoring future clinicians and researchers.
  3. Pioneering innovative therapeutic approaches.
    ensures that her influence will resonate for years to come. Her future contributions are expected to address emerging challenges in respiratory health and critical care, particularly in aging populations.

🛠 OTHER IMPORTANT TOPICS

💡 MULTIDISCIPLINARY APPROACH

Dr. Wang advocates for collaboration across specialties to improve patient care and advance research. Her work integrates insights from immunology, pharmacology, and critical care practices.


🎓 EDUCATION AND TRAINING INITIATIVES

Dr. Wang is actively involved in teaching and training, emphasizing evidence-based practices to cultivate the next generation of respiratory care professionals. He exemplifies excellence in respiratory and critical care medicine, with a career characterized by impactful research, clinical leadership, and an enduring commitment to improving patient outcomes.


✨CONCLUSION:

Dr. Na Wang stands as a beacon of excellence in Respiratory and Critical Care Medicine, particularly in the management and research of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD). Her journey from a dedicated academic to an influential clinician and researcher reflects her unwavering commitment to advancing healthcare. Through groundbreaking research, impactful teaching, and exemplary clinical practice, Dr. Wang has significantly shaped the field, improving the lives of countless patients and setting a high standard for future contributions.

📊🔬NOTABLE PUBLICATION:
  • The association between chronic obstructive pulmonary disease and autoimmune diseases: a bidirectional Mendelian randomization study
    • Authors: Yu, X., Cheng, X., Lv, L., … Hu, T., Shi, Z.
    • Journal: Frontiers in Medicine
    • Year: 2024

  • A left pulmonary artery sling with left bronchiectasis in an adult patient: A case report and review of literature
    • Authors: Lv, L., Cheng, X., Yu, X., … Liu, J., Shi, Z.
    • Journal: Respirology Case Reports
    • Year: 2023

  • Prolonged elevated heart rate is associated with adverse outcome in severe pulmonary embolism: A retrospective study
    • Authors: Wang, G., Liu, T., Ji, W., … Hu, T., Shi, Z.
    • Journal: International Journal of Cardiology
    • Year: 2024

  • Association between prognostic nutritional index and mortality risk in patients with community-acquired pneumonia: a retrospective study
    • Authors: Wang, G., Wang, N., Liu, T., … Hu, T., Shi, Z.
    • Journal: BMC Pulmonary Medicine
    • Year: 2024

  • Development and validation of a nomogram for assessing survival in acute exacerbation of chronic obstructive pulmonary disease patients
    • Authors: Wang, N., Li, M., Wang, G., … Hu, T., Shi, Z.
    • Journal: BMC Pulmonary Medicine
    • Year: 2024